Partner Therapeutics’ Leukine® (sargramostim) Receives Approval in Japan to Treat Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
Treatment will be Marketed by Nobelpharma Co. Ltd. Under the Trade Name Sargmalin® PMDA Approval of Sargmalin is the first regulatory approval of an inhaled recombinant GM-CSF product for aPAP LEXINGTON, Mass., April 3, 2024 /PRNewswire/ — Partner Therapeutics, Inc. (PTx) announced that its p
Media Advisory – Deputy Prime Minister’s itinerary for Thursday, April 4, 2024
OTTAWA, ON, April 3, 2024 /CNW/ – Note: All times local. Toronto, Ontario 11:30 a.m. The Deputy Prime Minister will tour an affordable rental apartment building and make a housing announcement in advance of the 2024 federal budget. A media availability will follow. Notes for media:
oneZero earns 2024 Great Place To Work Australia Certification™
SYDNEY, April 4, 2024 /PRNewswire/ — oneZero, a global leader in multi-asset enterprise trading technology solutions, is proud to be certified as a Great Place To Work® in Australia. The prestigious award is issued based on objective feedback from employees in the Australia region. The recogn
Eupraxia Pharmaceuticals to Begin Trading on Nasdaq on April 5, 2024
Company’s Listing Application Approved by Nasdaq VICTORIA, BC, April 3, 2024 /PRNewswire/ – Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (TSX: EPRX); (NASDAQ: EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ t
Richmond American Set to Build New Neighborhood in Volusia County
Grandview Gardens addition will offer new homes with open layouts and designer details DELAND, Fla., April 3, 2024 /PRNewswire/ — Richmond American Homes of Florida, LP, a subsidiary of M.D.C. Holdings, Inc. (NYSE: MDC), is pleased to announce that it recently purchased and closed on 70 hom
BlackBerry Reports Fourth Quarter and Full Fiscal Year 2024 Results
Delivers year-over-year revenue growth for both IoT and Cybersecurity divisionsIoT division reports record revenue quarter and QNX royalty backlog of $815 millionCybersecurity division stabilizes ARR, with sequential growth and DBNRR improvementSignificantly improves operating cash usage sequentiall
Riley Permian Announces Commencement of Public Offering of Common Stock
OKLAHOMA CITY, April 3, 2024 /PRNewswire/ — Riley Exploration Permian, Inc. (NYSE American: REPX) (“Riley Permian” or the “Company”) announced today that it has commenced an underwritten public offering of 2,100,000 shares of its common stock (the “Offering”
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages The Chemours Company Investors to Secure Counsel Before Important Deadline in Securities Class Action – CC
NEW YORK, April 3, 2024 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of The Chemours Company (NYSE: CC) between February 10, 2023 and February 28, 2024, both dates inclusive (the “Class Period”), of the important May 20,
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation – COCH
NEW YORK, April 3, 2024 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Envoy Medical, Inc. (NASDAQ: COCH) resulting from allegations that Envoy may have issued materially misleading busin
Ryerson to Host Earnings Call on Wednesday, May 1st, to Discuss First Quarter 2024 Results
CHICAGO, April 3, 2024 /PRNewswire/ — Ryerson Holding Corporation (NYSE: RYI), a leading value-added processor and distributor of industrial metals, announced today that it will host a conference call to discuss its first quarter 2024 financial results for the period ended March 31, 2024, on W